• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在6-羟基多巴胺动物模型中,阻断快速A型和四乙铵敏感钾通道可产生抗帕金森病效应。

Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.

作者信息

Haghdoost-Yazdi Hashem, Piri Hossein, Najafipour Reza, Faraji Ayda, Fraidouni Negin, Dargahi Tahereh, Alipour Heidari Mahmud

机构信息

Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

出版信息

Neurosciences (Riyadh). 2017 Jan;22(1):44-50. doi: 10.17712/nsj.2017.1.20160266.

DOI:10.17712/nsj.2017.1.20160266
PMID:28064330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5726837/
Abstract

OBJECTIVE

To evaluate the effect of K+ channels inhibitors in treatment of parkinson`s disease (PD).

METHODS

This prospective comparative study was conducted in the Qazvin University of Medical Sciences, Iran, from April 2015 to January 2016. Male rats (n=37) received intraperitoneal doses of TEA (2 and 5 mg/kg) or 4-AP (0.5 and 1 mg/kg) twice-daily, before a stereotactic injection of 6-hydroxydopamine (6-OHDA) for the following 7 days. The 6-OHDA was injected into right medial forebrain bundle (MFB) of the rat brains. Development and severity of PD were assessed using the apomorphine-induced rotational test, the elevated body swing test and rotarod tests. Concentration of malondialdehyde (MDA), a marker of oxidative stress, was measured in rat sera.

RESULTS

Tetraethylammonium and 4-AP significantly reduced the number of apomorphine-induced rotations and improved motor learning in the rotarod test at both doses. Administration of 4-AP and TEA together was more effective than single administration of either agent. Malondialdehyde measurement showed that pretreatment with TEA could not prevent 6-OHDA-induced oxidative stress.

CONCLUSION

Our results showed that pretreatment with TEA and 4-AP has a neuroprotective effect against 6-OHDA in dopaminergic neurons in the substantia nigra.

摘要

目的

评估钾通道抑制剂对帕金森病(PD)的治疗效果。

方法

这项前瞻性比较研究于2015年4月至2016年1月在伊朗加兹温医科大学进行。雄性大鼠(n = 37)在立体定向注射6-羟基多巴胺(6-OHDA)前7天,每天两次腹腔注射TEA(2和5mg/kg)或4-AP(0.5和1mg/kg)。将6-OHDA注入大鼠脑右侧内侧前脑束(MFB)。使用阿扑吗啡诱导的旋转试验、抬高身体摆动试验和转棒试验评估PD的发展和严重程度。测量大鼠血清中氧化应激标志物丙二醛(MDA)的浓度。

结果

两种剂量的四乙铵和4-AP均显著减少了阿扑吗啡诱导的旋转次数,并改善了转棒试验中的运动学习能力。联合使用4-AP和TEA比单独使用任何一种药物更有效。丙二醛测量表明,TEA预处理不能预防6-OHDA诱导的氧化应激。

结论

我们的结果表明,TEA和4-AP预处理对黑质多巴胺能神经元中的6-OHDA具有神经保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/ab5bb7839495/Neurosciences-22-44-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/fb7621cb66d0/Neurosciences-22-44-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/536cbc29b2e5/Neurosciences-22-44-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/593f04e546d3/Neurosciences-22-44-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/c0b7260bb1cb/Neurosciences-22-44-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/ab5bb7839495/Neurosciences-22-44-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/fb7621cb66d0/Neurosciences-22-44-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/536cbc29b2e5/Neurosciences-22-44-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/593f04e546d3/Neurosciences-22-44-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/c0b7260bb1cb/Neurosciences-22-44-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d7/5726837/ab5bb7839495/Neurosciences-22-44-g005.jpg

相似文献

1
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.在6-羟基多巴胺动物模型中,阻断快速A型和四乙铵敏感钾通道可产生抗帕金森病效应。
Neurosciences (Riyadh). 2017 Jan;22(1):44-50. doi: 10.17712/nsj.2017.1.20160266.
2
Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.4- 氨基吡啶和四乙铵在治疗 6- 羟多巴胺诱导的帕金森病中的显著作用。
Behav Brain Res. 2011 Sep 30;223(1):70-4. doi: 10.1016/j.bbr.2011.04.021. Epub 2011 Apr 21.
3
Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.用钾通道阻滞剂4-氨基吡啶和四乙铵进行预处理可减轻纹状体内注射6-羟基多巴胺诱导的帕金森病行为症状;脂质过氧化的作用。
Neurol Res. 2016 Apr;38(4):294-300. doi: 10.1080/01616412.2015.1114290. Epub 2016 Apr 21.
4
Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.硫化氢在急性6-羟基多巴胺诱导的帕金森病动物模型中的抗帕金森病及神经保护作用评估:行为学、组织学和生物化学研究
Neurol Res. 2018 Jul;40(7):523-531. doi: 10.1080/01616412.2017.1390903. Epub 2018 May 4.
5
Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.三磷酸腺苷敏感性钾通道参与硫化氢在6-羟基多巴胺诱导的帕金森病动物模型中的神经保护活性。
Behav Pharmacol. 2018 Jun;29(4):336-343. doi: 10.1097/FBP.0000000000000358.
6
Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model.染料木黄酮对6-羟基多巴胺半帕金森病大鼠模型的神经保护作用
Phytother Res. 2009 Jan;23(1):132-5. doi: 10.1002/ptr.2564.
7
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.小鼠帕金森病单侧6-羟基多巴胺损伤模型的行为特征
Behav Brain Res. 2005 Jul 1;162(1):1-10. doi: 10.1016/j.bbr.2005.02.023.
8
Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model.血清尿酸水平的变化可预测 6-羟多巴胺动物模型中帕金森病的发展。
Neurochem Res. 2018 May;43(5):1086-1095. doi: 10.1007/s11064-018-2522-y. Epub 2018 Apr 3.
9
Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.司罗芬酸可预防6-羟基多巴胺诱导的半帕金森病大鼠黑质神经退行性变及药物诱导的旋转不对称。
J Neurochem. 2005 Nov;95(4):950-61. doi: 10.1111/j.1471-4159.2005.03413.x. Epub 2005 Aug 31.
10
Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.褪黑素对偏侧帕金森病大鼠模型中6-羟基多巴胺诱导的氧化应激具有保护作用。
Free Radic Res. 2015;49(8):1004-14. doi: 10.3109/10715762.2015.1027198. Epub 2015 Apr 25.

引用本文的文献

1
4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.4-氨基吡啶保护 MPTP 诱导的帕金森病小鼠模型中黑质多巴胺能神经元。
Neurochem Res. 2023 Jun;48(6):1707-1715. doi: 10.1007/s11064-022-03845-0. Epub 2023 Jan 5.
2
Ghrelin Reduces A-Type Potassium Currents in Dopaminergic Nigral Neurons via the PLC/PKCδ Pathway.胃饥饿素通过磷脂酶C/蛋白激酶Cδ途径降低多巴胺能黑质神经元的A型钾电流。
Neurosci Bull. 2020 Aug;36(8):947-950. doi: 10.1007/s12264-020-00508-4. Epub 2020 May 9.
3
Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.

本文引用的文献

1
Resveratrol-Dependent Down-regulation of Receptor for Advanced Glycation End-products and Oxidative Stress in Kidney of Rats With Diabetes.白藜芦醇对糖尿病大鼠肾脏晚期糖基化终产物受体及氧化应激的依赖性下调作用
Int J Endocrinol Metab. 2015 Apr 20;13(2):e23542. doi: 10.5812/ijem.23542. eCollection 2015 Apr.
2
Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.4- 氨基吡啶和四乙铵在治疗 6- 羟多巴胺诱导的帕金森病中的显著作用。
Behav Brain Res. 2011 Sep 30;223(1):70-4. doi: 10.1016/j.bbr.2011.04.021. Epub 2011 Apr 21.
3
Potassium channel blocker, 4-aminopyridine-3-methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis.
香芹酚可预防帕金森病体内和体外模型中 6-羟多巴胺诱导的神经毒性。
Neurotox Res. 2020 Jan;37(1):156-170. doi: 10.1007/s12640-019-00088-w. Epub 2019 Jul 30.
4
Mechanisms by which fibroblast growth factor 20 improves motor performance in a mouse model of Parkinson's disease.成纤维细胞生长因子20改善帕金森病小鼠模型运动功能的机制。
Neural Regen Res. 2019 Aug;14(8):1438-1444. doi: 10.4103/1673-5374.253527.
5
Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease.钾通道:帕金森病的潜在治疗靶点。
Neurosci Bull. 2018 Apr;34(2):341-348. doi: 10.1007/s12264-017-0177-3. Epub 2017 Sep 7.
钾通道阻滞剂 4-氨基吡啶-3-甲醇可恢复多发性硬化症动物模型脊髓中的轴突传导。
Exp Neurol. 2011 Jan;227(1):232-5. doi: 10.1016/j.expneurol.2010.11.004. Epub 2010 Nov 17.
4
The roles of I(D), I(A) and I(K) in the electrophysiological functions of small diameter rat trigeminal ganglion neurons.I(D)、I(A) 和 I(K) 在大鼠小直径三叉神经节神经元电生理功能中的作用。
Curr Mol Pharmacol. 2010 Jan;3(1):30-6. doi: 10.2174/1874467211003010030.
5
Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit.氨基吡啶类药物通过靶向电压激活钙通道β亚基增强突触和神经肌肉传递。
J Biol Chem. 2009 Dec 25;284(52):36453-36461. doi: 10.1074/jbc.M109.075523. Epub 2009 Oct 22.
6
Aminopyridines for the treatment of cerebellar and ocular motor disorders.用于治疗小脑和眼球运动障碍的氨基吡啶类药物。
Prog Brain Res. 2008;171:535-41. doi: 10.1016/S0079-6123(08)00676-6.
7
Potassium channels: possible new therapeutic targets in Parkinson's disease.钾通道:帕金森病潜在的新治疗靶点
Med Hypotheses. 2008 Oct;71(4):546-50. doi: 10.1016/j.mehy.2008.05.021. Epub 2008 Jul 22.
8
Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson's disease.基底神经节中的钾通道:治疗帕金森病的有前景的新靶点。
Front Biosci. 2008 May 1;13:3685-98. doi: 10.2741/2959.
9
Iberiotoxin-sensitive large conductance Ca2+ -dependent K+ (BK) channels regulate the spike configuration in the burst firing of cerebellar Purkinje neurons.对埃博毒素敏感的大电导钙依赖性钾(BK)通道调节小脑浦肯野神经元爆发式放电的峰电位形态。
Brain Res. 2008 May 30;1212:1-8. doi: 10.1016/j.brainres.2008.03.030. Epub 2008 Mar 27.
10
The role of small-conductance Ca2+-activated K+ channels in the modulation of 4-aminopyridine-induced burst firing in rat cerebellar Purkinje cells.小电导钙激活钾通道在调节4-氨基吡啶诱导的大鼠小脑浦肯野细胞爆发式放电中的作用
Brain Res. 2007 Jul 2;1156:59-66. doi: 10.1016/j.brainres.2007.04.031. Epub 2007 Apr 18.